Péter Sárosi on the struggle to fund harm reduction in Hungary
Following a workshop in Budapest on how to secure sustainable funding for harm reduction in Central and Eastern Europe, Jeffrey Lazarus has been speaking with… Read more »
Prof Jeffrey V. Lazarus is on the faculty at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona and at CHIP, the Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He also serves as the Board Chair of AFEW International, a Board member of the EASL International Liver Foundation, a steering committee member of the HIV in Europe Initiative, the ACHIEVE Hepatitis Elimination coalition and of the European Commission’s joint action on HIV and hepatitis. He is a member of the BMC Editorial Advisory Group.
Latest posts by Jeffrey V. Lazarus (see all)
- The challenge of sustainable funding – Jurgita Poškevičiūtė on financing harm reduction in Lithuania - 7th March 2018
- Unlocking state money for harm reduction – Darko Antik on helping NGOs in Macedonia - 23rd February 2018
- Securing crucial funding for harm reduction in a challenging setting: Iva Jovović discusses LET, the quality-of-life improvement NGO in Croatia - 18th October 2017
HIV 4 years from now…
Today is the last day of the 4YFN Conference at Mobile World Congress Barcelona in the historic Fira Montjuïc. As digital start-ups come together from all over… Read more »
An interview with Patrick Hoffmann of the Health Directorate Luxembourg on the European Joint Action’s impact on harm reduction in prisons
Here’s my interview with Patrick Hoffmann, health inspector, Health Directorate in Luxembourg and partner in the HA-REACT Joint Action. What influenced your… Read more »
Connecting the dots on World AIDS Day with the European Joint Action to end HIV
This blog, co-authored by EU Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) coordinator Mika Salminen and steering committee… Read more »
‘Tis the season to get tested
Who has hepatitis? Well, that’s a good question. We know that some groups are more likely to acquire HCV infection than others. But, unfortunately, most… Read more »
An interview with Emilis Subata on the European Joint Action’s work on sustainable & long-term funding for HIV, TB and HCV
The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including… Read more »
Learning from each other: budget advocacy for harm reduction
The evidence is unequivocal: harm reduction saves lives and money. Yet NGOs have long fought an uphill battle to get funding for needle exchanges and opioid… Read more »
An interview with Luis Sordo del Castillo on the European Joint Action’s work on harm reduction
The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including… Read more »
An interview with Piotr Wysocki and Iwona Wawer on the European Joint Action’s work from a Polish-partner perspective
The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including… Read more »
An interview with Heino Stöver on the European Joint Action’s work on infectious diseases in prisons
The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including… Read more »